These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 32304142
1. Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model. de Conti A, Tryndyak V, Willett RA, Borowa-Mazgaj B, Watson A, Patton R, Khare S, Muskhelishvili L, Olson GR, Avigan MI, Cerniglia CE, Ross SA, Sanyal AJ, Beland FA, Rusyn I, Pogribny IP. FASEB J; 2020 Jun; 34(6):7773-7785. PubMed ID: 32304142 [Abstract] [Full Text] [Related]
2. Effect of an obesogenic high-fat and high-sucrose diet on hepatic gene expression signatures in male Collaborative Cross mice. Tryndyak VP, Willett RA, Nagumalli SK, Li D, Avigan MI, Beland FA, Rusyn I, Pogribny IP. Am J Physiol Gastrointest Liver Physiol; 2023 Mar 01; 324(3):G232-G243. PubMed ID: 36625475 [Abstract] [Full Text] [Related]
5. Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet. Tryndyak VP, Willett RA, Avigan MI, Sanyal AJ, Beland FA, Rusyn I, Pogribny IP. Epigenetics; 2022 Nov 01; 17(11):1462-1476. PubMed ID: 35324388 [Abstract] [Full Text] [Related]
6. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice. Kubo H, Hoshi M, Matsumoto T, Irie M, Oura S, Tsutsumi H, Hata Y, Yamamoto Y, Saito K. Lipids Health Dis; 2017 Jun 03; 16(1):106. PubMed ID: 28578672 [Abstract] [Full Text] [Related]
7. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease. Zhang J, Li S, Li J, Han C, Wang Z, Li C, Wang X, Liu Z, Wen J, Zheng L. Chin Med J (Engl); 2014 Jun 03; 127(21):3771-6. PubMed ID: 25382334 [Abstract] [Full Text] [Related]
8. A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice. Willett RA, Tryndyak VP, Hughes Hanks JM, Elkins L, Nagumalli SK, Avigan MI, Ross SA, da Costa GG, Beland FA, Rusyn I, Pogribny IP. Toxicol Appl Pharmacol; 2024 Oct 03; 491():117046. PubMed ID: 39084266 [Abstract] [Full Text] [Related]
13. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice. Cheng X, Yamauchi J, Lee S, Zhang T, Gong Z, Muzumdar R, Qu S, Dong HH. J Biol Chem; 2017 Mar 03; 292(9):3692-3705. PubMed ID: 28115523 [Abstract] [Full Text] [Related]
14. Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice. Wang X, Ren Q, Wu T, Guo Y, Liang Y, Liu S. Mol Med Rep; 2014 Dec 03; 10(6):2917-23. PubMed ID: 25310357 [Abstract] [Full Text] [Related]
17. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice. Wilson CG, Tran JL, Erion DM, Vera NB, Febbraio M, Weiss EJ. Endocrinology; 2016 Feb 03; 157(2):570-85. PubMed ID: 26650570 [Abstract] [Full Text] [Related]
18. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD. Luo Y, Burrington CM, Graff EC, Zhang J, Judd RL, Suksaranjit P, Kaewpoowat Q, Davenport SK, O'Neill AM, Greene MW. Am J Physiol Endocrinol Metab; 2016 Mar 15; 310(6):E418-39. PubMed ID: 26670487 [Abstract] [Full Text] [Related]